These launches are what Oelrich called “must-win battles” at Bayer as the Xarelto loss of exclusivity reaches “full swing” in ...
Bayer will focus on paying down debt and not make any major acquisitions in the next two or three years, the head of the ...
In a bold move to restore profitability, Bayer CEO Bill Anderson cut out most of the company’s management roles last year.
Chemical company Monsanto — owned by Bayer — was found liable this week by a jury for harm caused to students and parents at ...
Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” fourth quarter 2024 investor letter. A ...
Bayer said Thursday it has acquired camelina germplasm, intellectual property, and materials from Smart Earth Camelina Corp.
The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...